Literature DB >> 30697504

Artemisinin: A Promising Adjunct for Cancer Therapy.

Yamna Waseem1, Choudhary A Hasan1, Furqan Ahmed2.   

Abstract

Artemisinin is a herb derived from Artemesia annua (also known as sweet wormwood) and is known for its use as effective antimalarial pharmacotherapy. Recent studies have shown that artemisinin has anti-angiogenic and growth inhibition effects, as well as an apoptotic ability secondary to its inherent endo-peroxidase activity.

Entities:  

Keywords:  artmesinin; cancer; malaria

Year:  2018        PMID： 30697504      PMCID： PMC6347441          DOI： 10.7759/cureus.3628

Source DB:  PubMed          Journal:  Cureus        ISSN： 2168-8184


  3 in total

Review 1.  Targeted treatment of cancer with artemisinin and artemisinin-tagged iron-carrying compounds.

Authors:  Henry Lai; Tomikazu Sasaki; Narendra P Singh
Journal:  Expert Opin Ther Targets       Date:  2005-10       Impact factor: 6.902

2.  Survey of artemisinin production by diverse Artemisia species in northern Pakistan.

Authors:  Abdul Mannan; Ibrar Ahmed; Waheed Arshad; Muhammad F Asim; Rizwana A Qureshi; Izhar Hussain; Bushra Mirza
Journal:  Malar J       Date:  2010-11-04       Impact factor: 2.979

3.  Mechanistic Investigation of the Specific Anticancer Property of Artemisinin and Its Combination with Aminolevulinic Acid for Enhanced Anticolorectal Cancer Activity.

Authors:  Jigang Wang; Jianbin Zhang; Yin Shi; Chengchao Xu; Chongjing Zhang; Yin Kwan Wong; Yew Mun Lee; Sanjeev Krishna; Yingke He; Teck Kwang Lim; Weiying Sim; Zi-Chun Hua; Han-Ming Shen; Qingsong Lin
Journal:  ACS Cent Sci       Date:  2017-06-28       Impact factor: 14.553
  3 in total
  2 in total

1.  Dihydroartemisinin prevents palmitate-induced β-cell apoptosis.

Authors:  Zhiyong Wang; Yan Hao; Haibing Yu; Pei Wei
Journal:  Apoptosis       Date:  2021-02-19       Impact factor: 4.677

2.  Artesunate inhibits the mevalonate pathway and promotes glioma cell senescence.

Authors:  Shupei Wei; Lili Liu; Zhiyu Chen; Wenli Yin; Yingzi Liu; Qianying Ouyang; Feiyue Zeng; Yingjie Nie; Tao Chen
Journal:  J Cell Mol Med       Date:  2019-11-20       Impact factor: 5.310
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.